Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice

Nutrients. 2021 Feb 3;13(2):501. doi: 10.3390/nu13020501.

Abstract

Obesity and aging are associated to non-alcoholic fatty liver disease (NAFLD) development. Here, we investigate whether long-term feeding with a docosahexaenoic acid (DHA)-enriched diet and aerobic exercise, alone or in combination, are effective in ameliorating NAFLD in aged obese mice. Two-month-old female C57BL/6J mice received control or high fat diet (HFD) for 4 months. Then, the diet-induced obese (DIO) mice were distributed into four groups: DIO, DIO + DHA (15% dietary lipids replaced by a DHA-rich concentrate), DIO + EX (treadmill running), and DIO + DHA + EX up to 18 months. The DHA-rich diet reduced liver steatosis in DIO mice, decreasing lipogenic genes (Dgat2, Scd1, Srebp1c), and upregulated lipid catabolism genes (Hsl/Acox) expression. A similar pattern was observed in the DIO + EX group. The combination of DHA + exercise potentiated an increase in Cpt1a and Ppara genes, and AMPK activation, key regulators of fatty acid oxidation. Exercise, alone or in combination with DHA, significantly reversed the induction of proinflammatory genes (Mcp1, Il6, Tnfα, Tlr4) in DIO mice. DHA supplementation was effective in preventing the alterations induced by the HFD in endoplasmic reticulum stress-related genes (Ern1/Xbp1) and autophagy markers (LC3II/I ratio, p62, Atg7). In summary, long-term DHA supplementation and/or exercise could be helpful to delay NAFLD progression during aging in obesity.

Keywords: ER stress; aging; autophagy; exercise; fatty acid oxidation; inflammation; lipogenesis; non-alcoholic fatty liver; obesity; omega-3 fatty acids.

MeSH terms

  • Aging / physiology*
  • Animals
  • Autophagy / genetics
  • Autophagy / physiology
  • Diet, High-Fat
  • Disease Models, Animal
  • Docosahexaenoic Acids / administration & dosage*
  • Endoplasmic Reticulum Stress / genetics
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Inflammation / genetics
  • Lipid Metabolism
  • Lipogenesis / genetics
  • Liver / chemistry
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / genetics
  • Non-alcoholic Fatty Liver Disease / prevention & control*
  • Obesity / complications*
  • Obesity / etiology
  • Physical Conditioning, Animal / physiology*
  • RNA, Messenger / analysis

Substances

  • RNA, Messenger
  • Docosahexaenoic Acids